Bulletin
Investor Alert

GW Pharmaceuticals PLC ADR

NAS: GWPH

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209686240/composite

$

134.80

Change

-0.93 -0.69%

Volume

Volume 329

Jan 15, 2021, 7:37 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209686240/composite

Previous close

$ 137.83

$ 135.73

Change

-2.10 -1.52%

Day low

Day high

$134.79

$141.50

Open
Open: 137.90

52 week low

52 week high

$67.98

$144.00

Open

Market cap

$4.23B

Average volume

374,524

P/E ratio

N/A

Rev. per Employee

$346,971

EPS

-1.75

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gwph

MarketWatch News on GWPH

  1. GW Pharmaceuticals sees Q4 sales $148 mln; FactSet consensus $141.2 mln

    7:04 a.m. Jan. 11, 2021

    - Tomi Kilgore

  2. Pot stocks pop ahead of U.S., UN votes on cannabis legalization

    3:33 p.m. Nov. 30, 2020

    - Jeremy C. Owens

  3. GW Pharmaceuticals Q3 product sales of Epidiolex $132.6 mln

    7:37 a.m. Nov. 3, 2020

    - Tomi Kilgore

  4. GW Pharmaceuticals Q3 revenue $137.1 mln vs. $91.0 mln; FactSet consensus $127.4 mln

    7:35 a.m. Nov. 3, 2020

    - Tomi Kilgore

  5. GW Pharmaceuticals Q3 per-share loss 3 cents vs. loss 4 cents a year ago

    7:34 a.m. Nov. 3, 2020

    - Tomi Kilgore

  6. GW Pharmaceuticals Q3 FactSet per-share loss consensus 5 cents

    7:34 a.m. Nov. 3, 2020

    - Tomi Kilgore

  7. GW Pharmaceuticals stock set to rally after initiation of Phase 3 trial of MS treatment

    7:20 a.m. Nov. 3, 2020

    - Tomi Kilgore

  8. GW Pharmaceuticals, Momenta Pharmaceuticals and Zogenix all started at market perform at Raymond James

    7:17 a.m. Aug. 25, 2020

    - Tonya Garcia

  9. GW Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    6:08 a.m. July 15, 2020

    - Tomi Kilgore

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gwph

Other News on GWPH

  1. Aphria’s earnings beat consensus as pot stocks rally

    3:49 p.m. Jan. 14, 2021

    - Seeking Alpha

  2. 39th Annual JPMorgan Virtual Healthcare Conference

    2:55 p.m. Jan. 12, 2021

    - Seeking Alpha

  3. J.P. Morgan Believes GW Pharma (GWPH) Won’t Stop Here

    12:47 p.m. Jan. 12, 2021

    - SmarterAnalyst

  4. The Top 7 Marijuana Stocks to Buy for January

    11:39 a.m. Jan. 12, 2021

    - InvestorPlace.com

  5. U.S. Cannabis Companies Set To Soar

    1:52 p.m. Jan. 11, 2021

    - Seeking Alpha

  6. GW Pharmaceuticals foresees Q4 revenue above consensus

    1:00 p.m. Jan. 11, 2021

    - Seeking Alpha

  7. Wall Street Analysts Are Bullish on Top Healthcare Picks

    12:16 p.m. Jan. 11, 2021

    - SmarterAnalyst

  8. Why Lululemon Raised Earnings Guidance to High End of Range

    9:14 a.m. Jan. 11, 2021

    - 247WallSt.com

  9. Cannabis Goes Green With Blue Victory, U.S. Stocks Will Soar

    12:29 a.m. Jan. 11, 2021

    - Seeking Alpha

  10. The Non-Executive of GW Pharma is Exercising Options

    3:03 a.m. Jan. 8, 2021

    - SmarterAnalyst

  11. The Non-Executive of GW Pharma is Exercising Options

    1:05 a.m. Jan. 8, 2021

    - SmarterAnalyst

  12. Cannabis Stocks: Outlook For 2021 And What To Look For

    4:02 a.m. Jan. 4, 2021

    - Seeking Alpha

  13. Seeking Alpha Catalyst Watch

    1:30 p.m. Dec. 31, 2020

    - Seeking Alpha

  14. The Fastest Growing Cannabis Stocks And The Ones To Watch

    11:02 a.m. Dec. 27, 2020

    - Seeking Alpha

  15. The 20 Most Undervalued Cannabis Stocks

    8:42 a.m. Dec. 21, 2020

    - Seeking Alpha

  16. The Chairman of GW Pharma (GWPH) is Selling Shares

    11:03 a.m. Dec. 15, 2020

    - SmarterAnalyst

  17. Cannabis REITs: High On Growth

    9:15 a.m. Dec. 15, 2020

    - Seeking Alpha

  18. Loading more headlines...
/news/pressrelease/company/us/gwph

Press Releases on GWPH

  1. Cannabis Companies Entered 2021 With a Bang

    9:14 a.m. Jan. 13, 2021

    - IAM Newswire

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.